nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—AR—autistic disorder	0.419	0.544	CbGaD
Danazol—CYP19A1—autistic disorder	0.351	0.456	CbGaD
Danazol—GNRHR—hindbrain—autistic disorder	0.00761	0.087	CbGeAlD
Danazol—CCL2—mouth—autistic disorder	0.00521	0.0596	CbGeAlD
Danazol—GNRHR—brainstem—autistic disorder	0.00436	0.0499	CbGeAlD
Danazol—SHBG—hindbrain—autistic disorder	0.00347	0.0396	CbGeAlD
Danazol—CCL2—eye—autistic disorder	0.00331	0.0379	CbGeAlD
Danazol—CCL2—forebrain—autistic disorder	0.00329	0.0376	CbGeAlD
Danazol—PGR—hindbrain—autistic disorder	0.00312	0.0357	CbGeAlD
Danazol—CCL2—telencephalon—autistic disorder	0.00302	0.0345	CbGeAlD
Danazol—ESR1—hindbrain—autistic disorder	0.00244	0.0279	CbGeAlD
Danazol—GNRHR—head—autistic disorder	0.00241	0.0276	CbGeAlD
Danazol—CCL2—digestive system—autistic disorder	0.00231	0.0264	CbGeAlD
Danazol—GNRHR—nervous system—autistic disorder	0.00228	0.0261	CbGeAlD
Danazol—Fluoxymesterone—PRLR—autistic disorder	0.0022	0.301	CrCbGaD
Danazol—GNRHR—central nervous system—autistic disorder	0.0022	0.0252	CbGeAlD
Danazol—GNRHR—cerebellum—autistic disorder	0.00215	0.0246	CbGeAlD
Danazol—SHBG—brainstem—autistic disorder	0.00199	0.0227	CbGeAlD
Danazol—CCL2—head—autistic disorder	0.00188	0.0215	CbGeAlD
Danazol—CCL2—nervous system—autistic disorder	0.00178	0.0204	CbGeAlD
Danazol—GNRHR—brain—autistic disorder	0.00175	0.02	CbGeAlD
Danazol—CCL2—central nervous system—autistic disorder	0.00172	0.0196	CbGeAlD
Danazol—CCL2—cerebellum—autistic disorder	0.00168	0.0192	CbGeAlD
Danazol—CYP19A1—forebrain—autistic disorder	0.00155	0.0178	CbGeAlD
Danazol—ESR1—brainstem—autistic disorder	0.0014	0.016	CbGeAlD
Danazol—AR—forebrain—autistic disorder	0.00138	0.0157	CbGeAlD
Danazol—CCL2—brain—autistic disorder	0.00136	0.0156	CbGeAlD
Danazol—ESR1—forebrain—autistic disorder	0.00135	0.0154	CbGeAlD
Danazol—AR—telencephalon—autistic disorder	0.00127	0.0145	CbGeAlD
Danazol—ESR1—telencephalon—autistic disorder	0.00124	0.0142	CbGeAlD
Danazol—SHBG—central nervous system—autistic disorder	0.001	0.0115	CbGeAlD
Danazol—PGR—head—autistic disorder	0.000989	0.0113	CbGeAlD
Danazol—SHBG—cerebellum—autistic disorder	0.000979	0.0112	CbGeAlD
Danazol—AR—digestive system—autistic disorder	0.000966	0.011	CbGeAlD
Danazol—ESR1—digestive system—autistic disorder	0.000948	0.0108	CbGeAlD
Danazol—Stanozolol—AR—autistic disorder	0.000942	0.129	CrCbGaD
Danazol—PGR—nervous system—autistic disorder	0.000937	0.0107	CbGeAlD
Danazol—PGR—central nervous system—autistic disorder	0.000902	0.0103	CbGeAlD
Danazol—CYP19A1—head—autistic disorder	0.00089	0.0102	CbGeAlD
Danazol—PGR—cerebellum—autistic disorder	0.000882	0.0101	CbGeAlD
Danazol—Oxandrolone—AR—autistic disorder	0.000848	0.116	CrCbGaD
Danazol—CYP19A1—nervous system—autistic disorder	0.000844	0.00965	CbGeAlD
Danazol—CYP19A1—central nervous system—autistic disorder	0.000812	0.00929	CbGeAlD
Danazol—SHBG—brain—autistic disorder	0.000795	0.0091	CbGeAlD
Danazol—AR—head—autistic disorder	0.000788	0.00901	CbGeAlD
Danazol—ESR1—head—autistic disorder	0.000773	0.00884	CbGeAlD
Danazol—AR—nervous system—autistic disorder	0.000747	0.00854	CbGeAlD
Danazol—ESR1—nervous system—autistic disorder	0.000733	0.00838	CbGeAlD
Danazol—AR—central nervous system—autistic disorder	0.000719	0.00822	CbGeAlD
Danazol—PGR—brain—autistic disorder	0.000717	0.00819	CbGeAlD
Danazol—ESR1—central nervous system—autistic disorder	0.000706	0.00807	CbGeAlD
Danazol—ESR1—cerebellum—autistic disorder	0.00069	0.00789	CbGeAlD
Danazol—CYP19A1—brain—autistic disorder	0.000645	0.00737	CbGeAlD
Danazol—AR—brain—autistic disorder	0.000571	0.00653	CbGeAlD
Danazol—ESR1—brain—autistic disorder	0.00056	0.00641	CbGeAlD
Danazol—Testolactone—CYP19A1—autistic disorder	0.00053	0.0724	CrCbGaD
Danazol—CYP3A4—digestive system—autistic disorder	0.000529	0.00605	CbGeAlD
Danazol—Testosterone Propionate—COMT—autistic disorder	0.000462	0.0631	CrCbGaD
Danazol—CYP3A4—nervous system—autistic disorder	0.000409	0.00468	CbGeAlD
Danazol—CYP3A4—central nervous system—autistic disorder	0.000394	0.0045	CbGeAlD
Danazol—Testosterone Propionate—AR—autistic disorder	0.000344	0.047	CrCbGaD
Danazol—Levonorgestrel—AR—autistic disorder	0.000335	0.0457	CrCbGaD
Danazol—Fluoxymesterone—AR—autistic disorder	0.000319	0.0436	CrCbGaD
Danazol—Levonorgestrel—CYP19A1—autistic disorder	0.00028	0.0383	CrCbGaD
Danazol—Methyltestosterone—AR—autistic disorder	0.000258	0.0352	CrCbGaD
Danazol—Methyltestosterone—CYP19A1—autistic disorder	0.000216	0.0295	CrCbGaD
Danazol—Progesterone—AR—autistic disorder	0.000158	0.0216	CrCbGaD
Danazol—Testosterone—MAOA—autistic disorder	0.000151	0.0206	CrCbGaD
Danazol—Testosterone—AR—autistic disorder	0.000149	0.0204	CrCbGaD
Danazol—Testosterone—CYP19A1—autistic disorder	0.000125	0.0171	CrCbGaD
Danazol—CCL2—Signaling Pathways—PRL—autistic disorder	4.12e-05	0.000305	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—SERPINE1—autistic disorder	4.11e-05	0.000304	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—autistic disorder	4.05e-05	0.0003	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GRM5—autistic disorder	4.03e-05	0.000299	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VIP—autistic disorder	4.03e-05	0.000299	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ADSL—autistic disorder	4e-05	0.000296	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—PIK3CG—autistic disorder	3.97e-05	0.000294	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HTR5A—autistic disorder	3.95e-05	0.000292	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—XDH—autistic disorder	3.92e-05	0.00029	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ADRB2—autistic disorder	3.91e-05	0.000289	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—OXTR—autistic disorder	3.91e-05	0.000289	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	3.9e-05	0.000289	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SCT—autistic disorder	3.87e-05	0.000286	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—STX1A—autistic disorder	3.85e-05	0.000285	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NPAS2—autistic disorder	3.85e-05	0.000285	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—POMC—autistic disorder	3.78e-05	0.00028	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PRL—autistic disorder	3.77e-05	0.000279	CbGpPWpGaD
Danazol—ESR1—Gene Expression—RORA—autistic disorder	3.73e-05	0.000276	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TCN2—autistic disorder	3.72e-05	0.000275	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	3.7e-05	0.000274	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ADM—autistic disorder	3.69e-05	0.000273	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GABBR1—autistic disorder	3.69e-05	0.000273	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—AVP—autistic disorder	3.67e-05	0.000272	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IGF2—autistic disorder	3.66e-05	0.000271	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—MAPK1—autistic disorder	3.63e-05	0.000268	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EIF4E—autistic disorder	3.63e-05	0.000268	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—MAPK1—autistic disorder	3.61e-05	0.000267	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PDE4B—autistic disorder	3.6e-05	0.000266	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ADRB2—autistic disorder	3.58e-05	0.000265	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ADA—autistic disorder	3.55e-05	0.000263	CbGpPWpGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—autistic disorder	3.55e-05	0.000262	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL6—autistic disorder	3.53e-05	0.000261	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	3.51e-05	0.00026	CbGpPWpGaD
Danazol—PGR—Gene Expression—AR—autistic disorder	3.51e-05	0.000259	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—OPRM1—autistic disorder	3.48e-05	0.000258	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PLA2G4A—autistic disorder	3.46e-05	0.000256	CbGpPWpGaD
Danazol—ESR1—Gene Expression—RPL10—autistic disorder	3.42e-05	0.000253	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GABBR2—autistic disorder	3.36e-05	0.000249	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MEF2C—autistic disorder	3.36e-05	0.000249	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AVP—autistic disorder	3.36e-05	0.000249	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	3.36e-05	0.000249	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IGF2—autistic disorder	3.35e-05	0.000248	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ITGB3—autistic disorder	3.28e-05	0.000242	CbGpPWpGaD
Danazol—ESR1—Gene Expression—EIF4E—autistic disorder	3.27e-05	0.000242	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—RORA—autistic disorder	3.24e-05	0.000239	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GZMB—autistic disorder	3.19e-05	0.000236	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PLA2G4A—autistic disorder	3.16e-05	0.000234	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP19A1—autistic disorder	3.14e-05	0.000232	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—SERPINE1—autistic disorder	3.13e-05	0.000232	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP19A1—autistic disorder	3.09e-05	0.000229	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HTR1B—autistic disorder	3.09e-05	0.000229	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—OXT—autistic disorder	3.09e-05	0.000229	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—IL2—autistic disorder	3.08e-05	0.000228	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MEF2C—autistic disorder	3.07e-05	0.000227	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HTR2A—autistic disorder	3.06e-05	0.000226	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL2—autistic disorder	3.06e-05	0.000226	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MAOB—autistic disorder	3.03e-05	0.000224	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	3.01e-05	0.000222	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ITGB3—autistic disorder	3e-05	0.000222	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HTR1D—autistic disorder	3e-05	0.000222	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—COMT—autistic disorder	2.91e-05	0.000216	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TSC2—autistic disorder	2.9e-05	0.000215	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GSTP1—autistic disorder	2.9e-05	0.000215	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—HRAS—autistic disorder	2.9e-05	0.000214	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—MAOA—autistic disorder	2.89e-05	0.000214	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.89e-05	0.000214	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PRLR—autistic disorder	2.88e-05	0.000213	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—COMT—autistic disorder	2.87e-05	0.000213	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—DRD1—autistic disorder	2.87e-05	0.000213	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TSC1—autistic disorder	2.87e-05	0.000213	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—GSTP1—autistic disorder	2.86e-05	0.000212	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—APOE—autistic disorder	2.84e-05	0.00021	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—LEP—autistic disorder	2.84e-05	0.00021	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TPH2—autistic disorder	2.82e-05	0.000209	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NTRK2—autistic disorder	2.8e-05	0.000207	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HTR2A—autistic disorder	2.8e-05	0.000207	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL2—autistic disorder	2.8e-05	0.000207	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GRM8—autistic disorder	2.78e-05	0.000206	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—DRD3—autistic disorder	2.78e-05	0.000206	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—DPYD—autistic disorder	2.77e-05	0.000205	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—IL6—autistic disorder	2.77e-05	0.000205	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL5—autistic disorder	2.73e-05	0.000202	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—WNT2—autistic disorder	2.7e-05	0.0002	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CALCA—autistic disorder	2.69e-05	0.000199	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PRKCB—autistic disorder	2.68e-05	0.000198	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GSTM1—autistic disorder	2.67e-05	0.000197	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GHR—autistic disorder	2.66e-05	0.000197	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TSC2—autistic disorder	2.66e-05	0.000197	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—GSTM1—autistic disorder	2.63e-05	0.000195	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PDE4A—autistic disorder	2.62e-05	0.000194	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.6e-05	0.000193	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—APOE—autistic disorder	2.6e-05	0.000192	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—LEP—autistic disorder	2.6e-05	0.000192	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CACNA1C—autistic disorder	2.58e-05	0.000191	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—APC—autistic disorder	2.57e-05	0.00019	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CG—autistic disorder	2.57e-05	0.00019	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EGF—autistic disorder	2.54e-05	0.000188	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ACADSB—autistic disorder	2.49e-05	0.000185	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—INPP1—autistic disorder	2.49e-05	0.000185	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.48e-05	0.000183	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AVPR1A—autistic disorder	2.45e-05	0.000181	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PRKCB—autistic disorder	2.45e-05	0.000181	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—POMC—autistic disorder	2.44e-05	0.000181	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—SERPINE1—autistic disorder	2.41e-05	0.000178	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PRL—autistic disorder	2.38e-05	0.000176	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GRM5—autistic disorder	2.37e-05	0.000175	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VIP—autistic disorder	2.37e-05	0.000175	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IGF1—autistic disorder	2.35e-05	0.000174	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—APC—autistic disorder	2.35e-05	0.000174	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CG—autistic disorder	2.35e-05	0.000174	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—DHFR—autistic disorder	2.35e-05	0.000174	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—MAPK1—autistic disorder	2.34e-05	0.000173	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EGF—autistic disorder	2.32e-05	0.000172	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—OXTR—autistic disorder	2.29e-05	0.00017	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SCT—autistic disorder	2.27e-05	0.000168	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ADRB2—autistic disorder	2.26e-05	0.000167	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—POMC—autistic disorder	2.23e-05	0.000165	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SERPINE1—autistic disorder	2.23e-05	0.000165	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—BTD—autistic disorder	2.22e-05	0.000164	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GABBR1—autistic disorder	2.17e-05	0.00016	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADM—autistic disorder	2.17e-05	0.00016	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IGF1—autistic disorder	2.15e-05	0.000159	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—MAPK1—autistic disorder	2.14e-05	0.000158	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EIF4E—autistic disorder	2.13e-05	0.000157	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AVP—autistic disorder	2.12e-05	0.000157	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PDE4B—autistic disorder	2.11e-05	0.000156	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF2—autistic disorder	2.11e-05	0.000156	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AR—autistic disorder	2.06e-05	0.000152	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—OPRM1—autistic disorder	2.04e-05	0.000151	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SERPINE1—autistic disorder	2.04e-05	0.000151	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PLA2G4A—autistic disorder	1.99e-05	0.000147	CbGpPWpGaD
Danazol—PGR—Gene Expression—SERPINE1—autistic disorder	1.98e-05	0.000146	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.98e-05	0.000146	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MEF2C—autistic disorder	1.94e-05	0.000143	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TDO2—autistic disorder	1.89e-05	0.00014	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ITGB3—autistic disorder	1.89e-05	0.00014	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—POMC—autistic disorder	1.88e-05	0.000139	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—HRAS—autistic disorder	1.88e-05	0.000139	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GZMB—autistic disorder	1.87e-05	0.000138	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HTR1B—autistic disorder	1.81e-05	0.000134	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—OXT—autistic disorder	1.81e-05	0.000134	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL2—autistic disorder	1.81e-05	0.000134	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL6—autistic disorder	1.8e-05	0.000133	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—DHCR7—autistic disorder	1.78e-05	0.000131	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HTR2A—autistic disorder	1.76e-05	0.00013	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.72e-05	0.000128	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—HRAS—autistic disorder	1.72e-05	0.000127	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—COMT—autistic disorder	1.71e-05	0.000126	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTP1—autistic disorder	1.7e-05	0.000126	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PTEN—autistic disorder	1.7e-05	0.000126	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MAOA—autistic disorder	1.7e-05	0.000125	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—DRD1—autistic disorder	1.69e-05	0.000125	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TSC1—autistic disorder	1.69e-05	0.000125	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—EXT1—autistic disorder	1.68e-05	0.000125	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC6A8—autistic disorder	1.68e-05	0.000125	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TSC2—autistic disorder	1.68e-05	0.000124	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CAT—autistic disorder	1.65e-05	0.000122	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL2—autistic disorder	1.65e-05	0.000122	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—autistic disorder	1.64e-05	0.000122	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NTRK2—autistic disorder	1.64e-05	0.000121	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LEP—autistic disorder	1.64e-05	0.000121	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOE—autistic disorder	1.64e-05	0.000121	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—DRD3—autistic disorder	1.63e-05	0.000121	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—DAO—autistic disorder	1.61e-05	0.000119	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL5—autistic disorder	1.6e-05	0.000118	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CALCA—autistic disorder	1.58e-05	0.000117	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PLA2G4A—autistic disorder	1.56e-05	0.000116	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTM1—autistic disorder	1.56e-05	0.000116	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PTEN—autistic disorder	1.55e-05	0.000115	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PRKCB—autistic disorder	1.55e-05	0.000114	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—UPB1—autistic disorder	1.54e-05	0.000114	CbGpPWpGaD
Danazol—AR—Gene Expression—SERPINE1—autistic disorder	1.51e-05	0.000112	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GPX1—autistic disorder	1.5e-05	0.000111	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APC—autistic disorder	1.48e-05	0.000109	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CG—autistic disorder	1.48e-05	0.000109	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EGF—autistic disorder	1.46e-05	0.000108	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ASMT—autistic disorder	1.43e-05	0.000106	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTM5—autistic disorder	1.43e-05	0.000106	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—POMC—autistic disorder	1.41e-05	0.000104	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PRL—autistic disorder	1.4e-05	0.000103	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAPK1—autistic disorder	1.38e-05	0.000102	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MTHFR—autistic disorder	1.38e-05	0.000102	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF1—autistic disorder	1.35e-05	0.0001	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC25A12—autistic disorder	1.35e-05	9.97e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADRB2—autistic disorder	1.32e-05	9.8e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC19A1—autistic disorder	1.31e-05	9.69e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SERPINE1—autistic disorder	1.29e-05	9.52e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOE—autistic disorder	1.29e-05	9.51e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK1—autistic disorder	1.26e-05	9.35e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AVP—autistic disorder	1.24e-05	9.2e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF2—autistic disorder	1.24e-05	9.16e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PLA2G4A—autistic disorder	1.17e-05	8.65e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ADSL—autistic disorder	1.17e-05	8.64e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—SERPINE1—autistic disorder	1.16e-05	8.59e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CG—autistic disorder	1.16e-05	8.58e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—XDH—autistic disorder	1.15e-05	8.47e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MEF2C—autistic disorder	1.14e-05	8.42e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—STX1A—autistic disorder	1.12e-05	8.32e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NPAS2—autistic disorder	1.12e-05	8.32e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ITGB3—autistic disorder	1.11e-05	8.2e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HRAS—autistic disorder	1.11e-05	8.2e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—POMC—autistic disorder	1.1e-05	8.17e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TCN2—autistic disorder	1.09e-05	8.03e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—autistic disorder	1.06e-05	7.85e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL2—autistic disorder	1.04e-05	7.7e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ADA—autistic disorder	1.04e-05	7.66e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HTR2A—autistic disorder	1.04e-05	7.66e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HRAS—autistic disorder	1.01e-05	7.5e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TSC2—autistic disorder	9.83e-06	7.28e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTEN—autistic disorder	9.8e-06	7.25e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—autistic disorder	9.71e-06	7.18e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LEP—autistic disorder	9.62e-06	7.12e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOE—autistic disorder	9.62e-06	7.12e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—RORA—autistic disorder	9.44e-06	6.99e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PRKCB—autistic disorder	9.07e-06	6.71e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MAOB—autistic disorder	8.85e-06	6.55e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—autistic disorder	8.81e-06	6.52e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APC—autistic disorder	8.68e-06	6.43e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CG—autistic disorder	8.68e-06	6.43e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EGF—autistic disorder	8.58e-06	6.35e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—POMC—autistic disorder	8.27e-06	6.12e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TPH2—autistic disorder	8.23e-06	6.09e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—DPYD—autistic disorder	8.09e-06	5.99e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK1—autistic disorder	7.97e-06	5.89e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF1—autistic disorder	7.95e-06	5.88e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTEN—autistic disorder	7.68e-06	5.68e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SERPINE1—autistic disorder	7.55e-06	5.59e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CACNA1C—autistic disorder	7.53e-06	5.57e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—DHFR—autistic disorder	6.85e-06	5.07e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HRAS—autistic disorder	6.39e-06	4.73e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—autistic disorder	6.12e-06	4.53e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL2—autistic disorder	6.11e-06	4.52e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTEN—autistic disorder	5.75e-06	4.25e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP19A1—autistic disorder	5.36e-06	3.97e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—COMT—autistic disorder	4.99e-06	3.69e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTP1—autistic disorder	4.96e-06	3.67e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MAOA—autistic disorder	4.95e-06	3.66e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CAT—autistic disorder	4.83e-06	3.57e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK1—autistic disorder	4.67e-06	3.46e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PLA2G4A—autistic disorder	4.56e-06	3.37e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTM1—autistic disorder	4.56e-06	3.37e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GPX1—autistic disorder	4.37e-06	3.23e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MTHFR—autistic disorder	4.03e-06	2.98e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HRAS—autistic disorder	3.75e-06	2.78e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOE—autistic disorder	3.75e-06	2.78e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—autistic disorder	3.59e-06	2.66e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CG—autistic disorder	3.39e-06	2.5e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—POMC—autistic disorder	3.22e-06	2.38e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—autistic disorder	2.57e-06	1.9e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTEN—autistic disorder	2.24e-06	1.66e-05	CbGpPWpGaD
